Skip to content

Search

Rallying together for child health

The Imogen Miranda Suleski Fellowship is an annual award for early-career post-doctoral researchers at The Kids Research Institute Australia.

Achieving lasting change in the Kimberley

Many people would be daunted when tasked with coordinating, from scratch, a new The Kids Research Institute Australia satellite site to service WA’s north. But not John Jacky

Telethon celebrates 50 years of raising funds and awareness

Maddox Ball and The Kids researcher Dr Ingrid Laing might not look like they have a lot in common but they share a very special bond.

Empowering the Institute's researchers

Billionaire Stan Perron has made donations to The Kids as part of the Stan Perron Charitable trust totaling $500,000 a year. Read more about his generosity

A life of caring and a passion to give - local legend Harvey Coates

Over 20 years Professor Harvey Oates has made financial contributions to The Kids totaling over 6 figures, as well as sitting on the board for 16 years.

Coping, hoping and helping - A mother and father's response to cystic fibrosis

At 6 weeks old David was diagnosed as having cystic fibrosis. His parents say that his involvement in research offers them their greatest hope for his future.

George Church's legacy lives on

Kojonup couple George and Trish Church ensured their legacy of generosity and kindness lived on, by including The Kids in their will. Read more.

One vaccine for life: Lessons from immune ontogeny

There remains a general misconception that the immune status of the fetus and neonate is immature or insufficient. However, emerging research in immune ontogeny prompts reconsideration of this orthodoxy, reframing this period instead as one of unique opportunity. Vaccine responses (qualitative and quantitative) vary between individuals, and across demographic cohorts. Elements of baseline immune status and function predict vaccine response - some of these factors are well described, others remain a subject of ongoing research, especially with the rapidly expanding field of 'omics' research, enabled by development of highly granular immune profiling techniques and increasing computational capacity.

Enhanced Neutralizing Antibody Responses to Rhinovirus C and Age-Dependent Patterns of Infection

Rhinovirus (RV) C can cause asymptomatic infection and respiratory illnesses ranging from the common cold to severe wheezing. The aim was to identify how age and other individual-level factors are associated with susceptibility to RV-C illnesses. Longitudinal data from the COAST (Childhood Origins of Asthma) birth cohort study were analyzed to determine relationships between age and RV-C infections. Neutralizing antibodies specific for RV-A and RV-C (three types each) were determined using a novel PCR-based assay.

Can the CHA2 DS2 -VA schema be used to decide on anticoagulant therapy in Aboriginal and other Australians with non-valvular atrial fibrillation?

The Australasian guidelines recommend use of the CHA2 DS2 -VA schema to stratify ischaemic stroke risk in patients with non-valvular atrial fibrillation (N-VAF) and determine risk thresholds for recommending oral anticoagulant (OAC) therapy. However, the CHA2 DS2 -VA score has not been validated in a representative Australian population cohort with N-VAF, including in Aboriginal people who are known to have a higher age-adjusted stroke risk than other Australians.